4-(1-((TERT-BUTYLDIMETHYLSILYL)OXY)-2-METHYLPROPAN-2-YL)BENZOIC ACID, 90.0%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((allyloxy)carbonyl)amino)propanoic acid, 98.0%, 10g

Dialysis membrane Membra-Cel, 25 mm, 152 m, 1 Piece(s)

4-{[3-(Trifluoromethyl)phenyl]sulfonyl}piperidinehydrochloride, 95.0%, 5g

2-Hydroxyethyl 4-nitrophenyl sulfide, 98.0%, 5g

(E)-4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenol, 100mg

(S)-1-((Benzyloxy)carbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid, 98%, 250mg

Ethyl 4'-hydroxy-[1,1'-biphenyl]-4-carboxylate, 95.0%, 1g

Piperidine, min 99%, for synthesis, 1L, glass packaging

2-Methyl-5-(4-methylpiperazin-1-yl)aniline, 95.0%, 1g

2'-Bromospiro[cyclopentane-1,9'-fluorene], 97%, 5g

Methyl 3-fluoro-5-nitrobenzoate, 95.0%, 10g

5-BROMO-7-ETHYL-1H-INDAZOLE, 95%, 1g